Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 4:05 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | Point72 Asset Management L.P. | 5,932,908 7.9% | 5,932,908 (New Position) | View |
| 2024-03-26 4:21 pm Purchase | 13G | FOX CORP FOXA | Point72 Asset Management L.P. | 12,046,118 5% | 12,046,118 (New Position) | View |
| 2024-03-25 4:33 pm Purchase | 13G | LENZ THERAPEUTICS INC LENZ | Point72 Asset Management L.P. | 1,882,693 7.4% | 1,882,693 (New Position) | View |
| 2024-03-07 4:15 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Point72 Asset Management L.P. | 3,921,226 6.3% | 3,921,226 (New Position) | View |
| 2024-02-29 4:31 pm Purchase | 13G | PULMONX CORP LUNG | Point72 Asset Management L.P. | 1,936,083 5% | 389,994 (+25.22%) | View |
| 2024-02-27 4:14 pm Purchase | 13G | LIBERTY MEDIA CORP DEL COM LIB LLYVA | Point72 Asset Management L.P. | 1,287,149 5% | 1,287,149 (New Position) | View |
| 2024-02-23 4:28 pm Purchase | 13G | VENTYX BIOSCIENCES INC VTYX | Point72 Asset Management L.P. | 3,017,093 5.1% | 3,017,093 (New Position) | View |
| 2024-02-23 4:15 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 4,432,602 5% | 435,057 (+10.88%) | View |
| 2024-02-21 4:16 pm Purchase | 13G | AGENUS INC AGEN | Point72 Asset Management L.P. | 28,268,500 6.8% | 28,267,387 (+2539747.26%) | View |
| 2024-02-14 4:20 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | Point72 Asset Management L.P. | 1,649,740 6.4% | 499,092 (+43.37%) | View |
| 2024-02-14 4:19 pm Purchase | 13G | PAGSEGURO DIGITAL LTD PAGS | Point72 Asset Management L.P. | 10,933,610 5.6% | 231,012 (+2.16%) | View |
| 2024-02-14 4:18 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Point72 Asset Management L.P. | 3,030,283 5.8% | 30,283 (+1.01%) | View |
| 2024-02-14 4:17 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management L.P. | 2,756,122 5% | -866,014 (-23.91%) | View |
| 2024-02-14 4:17 pm Sale | 13G | MADISON SQUARE GARDEN ENTMT CO MSGE | Point72 Asset Management L.P. | 2,299,168 5.6% | -4,445 (-0.19%) | View |
| 2024-02-14 4:16 pm Purchase | 13G | TPI COMPOSITES INC TPIC | Point72 Asset Management L.P. | 3,286,322 7.1% | 1,154,151 (+54.13%) | View |
| 2024-02-14 4:15 pm Purchase | 13G | MORPHIC HLDG INC MORF | Point72 Asset Management L.P. | 4,591,000 9.2% | 2,086,617 (+83.32%) | View |
| 2024-02-14 4:14 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Point72 Asset Management L.P. | 3,416,900 5.1% | -311,052 (-8.34%) | View |
| 2024-02-14 4:14 pm Purchase | 13G | CYBIN INC CYBN | Point72 Asset Management L.P. | 30,061,112 7.4% | 11,111,112 (+58.63%) | View |
| 2024-02-14 4:13 pm Purchase | 13G | HEALTH CATALYST INC HCAT | Point72 Asset Management L.P. | 4,159,454 7.2% | 1,334,524 (+47.24%) | View |
| 2024-02-14 4:12 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management L.P. | 758,185 8.6% | 758,185 (New Position) | View |